Auxilium (AUXL) Acquires Specialty Pharma Co. Actient
Tweet
Share
E-mailGet Alerts AUXL Hot Sheet
Join SI Premium – FREE
TCR has sold its portfolio company, Actient Holdings LLC (“Actient”), to Auxilium Pharmaceuticals Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company. Headquartered in Lake Forest, Illinois, Actient is a specialty pharmaceutical company focused on developing, acquiring and marketing products that significantly improve patient outcomes.
Actient was formed in March 2009 in partnership with GTCR. Through a series of five acquisitions, Actient built a diversified portfolio of commercial products and pipeline programs to create a unique specialty pharmaceutical company focused on the treatment of urological indications.
Jefferies LLC served as Actient’s financial advisor and Kirkland & Ellis LLP provided legal counsel.
Actient was formed in March 2009 in partnership with GTCR. Through a series of five acquisitions, Actient built a diversified portfolio of commercial products and pipeline programs to create a unique specialty pharmaceutical company focused on the treatment of urological indications.
Jefferies LLC served as Actient’s financial advisor and Kirkland & Ellis LLP provided legal counsel.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GTCR Is Said To Be In Talks To Buy Software Maker SPS Commerce - Bloomberg
- Oracle reports earnings today: AI spending bet faces its toughest test yet
- Yarrow Bioscience prices $150M public offering at $26 per share
Create E-mail Alert Related Categories
FDA, Mergers and Acquisitions, Private EquityRelated Entities
Jefferies & Co, GTCRSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
